Michael F Picco

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. pmc An evidence-based review of natalizumab therapy in the management of Crohn's disease
    Raja Gr Edula
    Mayo Clinic, Jacksonville, Florida, USA
    Ther Clin Risk Manag 5:935-42. 2009
  2. doi Procedure time and the determination of polypoid abnormalities with experience: implementation of a chromoendoscopy program for surveillance colonoscopy for ulcerative colitis
    Michael F Picco
    Department of Medicine, Division of Gastroenterology, Mayo Clinic, Jacksonville, FL 32224, USA
    Inflamm Bowel Dis 19:1913-20. 2013
  3. doi Inflammatory bowel disease in the elderly
    Michael F Picco
    Department of Medicine, Division of Gastroenterology, 4500 San Pablo Rd, Mayo Clinic, Jacksonville, FL 32224, USA
    Gastroenterol Clin North Am 38:447-62. 2009
  4. doi Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease
    Michael F Picco
    Division of Gastroenterology, Mayo Clinic, Jacksonville, Florida 32224, USA
    Am J Gastroenterol 104:2754-9. 2009
  5. ncbi Oral mesalamine and clinical remission are associated with a decrease in the extent of long-standing ulcerative colitis
    Michael F Picco
    Mayo Clinic, Jacksonville, Florida 32224, USA
    Inflamm Bowel Dis 12:537-42. 2006
  6. doi Increased odds of interval left-sided colorectal cancer after flexible sigmoidoscopy compared with colonoscopy in older patients in the United States: a population-based analysis of the SEER-Medicare linked database, 2001-2005
    Yize R Wang
    Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA
    Mayo Clin Proc 88:471-8. 2013
  7. doi Racial/Ethnic and regional differences in the prevalence of inflammatory bowel disease in the United States
    Yize R Wang
    Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA
    Digestion 88:20-5. 2013
  8. ncbi Enteral versus parenteral nutrition: the patient's preference
    James S Scolapio
    Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida 32224, USA
    JPEN J Parenter Enteral Nutr 26:248-50. 2002
  9. doi Intestinal ischemia in the elderly
    John R Cangemi
    Division of Gastroenterology, Department of Medicine, Mayo Clinic Florida, 4500 San Pablo Road, Jacksonville, FL 32224, USA
    Gastroenterol Clin North Am 38:527-40. 2009
  10. doi Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the United States
    Yize R Wang
    Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA
    Am J Gastroenterol 108:444-9. 2013

Collaborators

Detail Information

Publications15

  1. pmc An evidence-based review of natalizumab therapy in the management of Crohn's disease
    Raja Gr Edula
    Mayo Clinic, Jacksonville, Florida, USA
    Ther Clin Risk Manag 5:935-42. 2009
    ..In this review, evidence-based data on the indications, efficacy and safety of natalizumab will be presented and its role in the management of patients with Crohn's disease will be defined...
  2. doi Procedure time and the determination of polypoid abnormalities with experience: implementation of a chromoendoscopy program for surveillance colonoscopy for ulcerative colitis
    Michael F Picco
    Department of Medicine, Division of Gastroenterology, Mayo Clinic, Jacksonville, FL 32224, USA
    Inflamm Bowel Dis 19:1913-20. 2013
    ..We investigated these factors among endoscopists inexperienced in this technique...
  3. doi Inflammatory bowel disease in the elderly
    Michael F Picco
    Department of Medicine, Division of Gastroenterology, 4500 San Pablo Rd, Mayo Clinic, Jacksonville, FL 32224, USA
    Gastroenterol Clin North Am 38:447-62. 2009
    ..Distinguishing these conditions from IBD will significantly alter prognosis and treatment. Complications related to IBD and its treatment are common and must be recognized early to limit their impact in a vulnerable elderly population...
  4. doi Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease
    Michael F Picco
    Division of Gastroenterology, Mayo Clinic, Jacksonville, Florida 32224, USA
    Am J Gastroenterol 104:2754-9. 2009
    ..We determined whether immunomodulator use was associated with a lower risk of first surgery among patients with non-stricturing non-penetrating Crohn's disease...
  5. ncbi Oral mesalamine and clinical remission are associated with a decrease in the extent of long-standing ulcerative colitis
    Michael F Picco
    Mayo Clinic, Jacksonville, Florida 32224, USA
    Inflamm Bowel Dis 12:537-42. 2006
    ..To assess the influences of mesalamine use and clinical disease activity on the change of histologic extent with time...
  6. doi Increased odds of interval left-sided colorectal cancer after flexible sigmoidoscopy compared with colonoscopy in older patients in the United States: a population-based analysis of the SEER-Medicare linked database, 2001-2005
    Yize R Wang
    Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA
    Mayo Clin Proc 88:471-8. 2013
    ..To compare the proportion of interval left-sided colorectal cancers (CRCs) after flexible sigmoidoscopy vs colonoscopy in older patients and to identify factors associated with interval CRC...
  7. doi Racial/Ethnic and regional differences in the prevalence of inflammatory bowel disease in the United States
    Yize R Wang
    Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA
    Digestion 88:20-5. 2013
    ..The magnitude of racial/ethnic and regional differences in the prevalence of inflammatory bowel disease (IBD) in the United States remains largely unknown...
  8. ncbi Enteral versus parenteral nutrition: the patient's preference
    James S Scolapio
    Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida 32224, USA
    JPEN J Parenter Enteral Nutr 26:248-50. 2002
    ....
  9. doi Intestinal ischemia in the elderly
    John R Cangemi
    Division of Gastroenterology, Department of Medicine, Mayo Clinic Florida, 4500 San Pablo Road, Jacksonville, FL 32224, USA
    Gastroenterol Clin North Am 38:527-40. 2009
    ..This article reviews the clinical spectrum of mesenteric ischemia in the elderly with particular emphasis on the varied presentations, evaluation, and management of ischemic disorders of the intestines...
  10. doi Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the United States
    Yize R Wang
    Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA
    Am J Gastroenterol 108:444-9. 2013
    ..The aim of this study was to compare the rate of early/missed CRCs after colonoscopy among IBD and non-IBD patients, and identify factors associated with early/missed CRCs...
  11. ncbi Tobacco consumption and disease duration are associated with fistulizing and stricturing behaviors in the first 8 years of Crohn's disease
    Michael F Picco
    Department of Medicine, Gastroenterology Division, Mayo Clinic Jacksonville, Jacksonville, Florida 32224, USA
    Am J Gastroenterol 98:363-8. 2003
    ..Our aim was to determine the influence of genetic and environmental factors on the prevalence of inflammatory behavior among patients who have had CD for <8 yr...
  12. ncbi Colonoscopy in octogenarians: a prospective outpatient study
    Frank J Lukens
    Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida 32224, USA
    Am J Gastroenterol 97:1722-5. 2002
    ..The aims of this study were to prospectively determine differences between octogenarians and nonoctogenarians in adequacy of colonic preparation, success in completing colonoscopy, and complications of conscious sedation...
  13. ncbi Everything old is new again? A fresh look at corticosteroids in ulcerative colitis
    Michael F Picco
    Am J Gastroenterol 103:2517-8. 2008
    ..These results should prompt further study of this method of drug delivery to confirm efficacy, assess short-term and possibly long-term side effect, and determine whether this translates into better overall safety...
  14. ncbi Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study
    Kim L Isaacs
    University of North Carolina, Chapel Hill, North Carolina 27599 7032, USA
    Inflamm Bowel Dis 13:1250-5. 2007
    ..The efficacy of the nonabsorbable antibiotic rifaximin in patients with active acute or chronic pouchitis is unknown...
  15. ncbi Share and share alike? Twins and environmental risk factors for inflammatory bowel disease
    Michael F Picco
    Inflamm Bowel Dis 12:934-5. 2006